Novo Nordisk A/S (NVO)
128.64
+3.38
(+2.70%)
USD |
NYSE |
Apr 23, 16:00
128.90
+0.26
(+0.20%)
After-Hours: 20:00
Novo Nordisk Net Income (TTM): 12.15B for Dec. 31, 2023
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 12.15B |
| September 30, 2023 | 10.85B |
| June 30, 2023 | 9.516B |
| March 31, 2023 | 8.583B |
| December 31, 2022 | 7.869B |
| September 30, 2022 | 7.676B |
| June 30, 2022 | 7.647B |
| March 31, 2022 | 7.705B |
| December 31, 2021 | 7.608B |
| September 30, 2021 | 7.425B |
| June 30, 2021 | 7.121B |
| March 31, 2021 | 6.726B |
| December 31, 2020 | 6.436B |
| September 30, 2020 | 6.235B |
| June 30, 2020 | 6.136B |
| March 31, 2020 | 6.011B |
| December 31, 2019 | 5.844B |
| September 30, 2019 | 5.851B |
| June 30, 2019 | 5.741B |
| March 31, 2019 | 5.955B |
| December 31, 2018 | 6.139B |
| September 30, 2018 | 6.146B |
| June 30, 2018 | 6.281B |
| March 31, 2018 | 6.095B |
| December 31, 2017 | 5.776B |
| Date | Value |
|---|---|
| September 30, 2017 | 5.732B |
| June 30, 2017 | 5.658B |
| March 31, 2017 | 5.700B |
| December 31, 2016 | 5.642B |
| September 30, 2016 | 5.592B |
| June 30, 2016 | 5.371B |
| March 31, 2016 | 5.093B |
| December 31, 2015 | 5.191B |
| September 30, 2015 | 5.075B |
| June 30, 2015 | 4.983B |
| March 31, 2015 | 5.033B |
| December 31, 2014 | 4.722B |
| September 30, 2014 | 4.731B |
| June 30, 2014 | 4.715B |
| March 31, 2014 | 4.610B |
| December 31, 2013 | 4.483B |
| September 30, 2013 | 4.379B |
| June 30, 2013 | 4.190B |
| March 31, 2013 | 3.934B |
| December 31, 2012 | 3.698B |
| September 30, 2012 | 3.546B |
| June 30, 2012 | 3.391B |
| March 31, 2012 | 3.266B |
| December 31, 2011 | 3.191B |
| September 30, 2011 | 3.060B |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
5.741B
Minimum
Jun 2019
12.15B
Maximum
Dec 2023
7.533B
Average
7.425B
Median
Sep 2021
Net Income (TTM) Benchmarks
| Amgen Inc | 6.717B |
| AstraZeneca PLC | 5.955B |
| Sanofi SA | 5.859B |
| Viking Therapeutics Inc | -85.90M |
| Evaxion Biotech AS | -22.12M |